Care issues and medication review by Vella, Janis & Azzopardi, Lilian M.
10
Abstract 
Objective To undertake a pharmacist medication 
review for patients receiving chronic medication in a 
community pharmacy setting. 
Method Patients collecting their free medication 
from a specific community pharmacy through the 
‘Pharmacy of Your Choice’ (POYC) scheme had their 
medication records reviewed by a pharmacist to identify 
any drug- related problems. A questionnaire regarding the 
use of their medication, patient check- ups and medication 
compliance to their prescribed regimen was performed for 
each individual patient. 
Key findings Eighty patients were studied. 
The average number of medications per patient was 6 
medications. Forty- two patients (52.5%) claimed to pick 
up their repeat prescription when they visit their doctor. 
Thirty- one patients (39%) stated that they experienced 
medication side effects. From the pharmacist medication 
review it transpired that 19 patients (24%) were at a risk of 
clinically significant drug interactions. 
Conclusion Community pharmacists can help 
patients use their medication more effectively. They 
can support prescribers in the selection of the most 
appropriate therapy for the individual patient. In chronic 
disease management, pharmacist-led medication reviews 
can help optimize pharmacological therapy reducing 
medication-related problems. This can help achieve 
treatment goals and improve patients’ quality of life.
Key words Medication review, medication regimen, 
community pharmacist, patient monitoring.
Introduction 
The ‘Pharmacy of Your Choice’ (POYC) scheme was 
introduced in Malta in 2007. This is a scheme whereby 
people suffering from chronic diseases obtain their 
medicines for free through the public national health 
system from a private pharmacy of their choice.  
Regimens, pertaining to patients who intend to make 
use of their medication chronically, might need certain 
periodic adjustments. Common amendments which 
can be made include the removal of unnecessary 
medication or the addition of another drug. In chronic 
treatment patients may need medication review especially 
when receiving treatment from different health care 
professionals.   Some patients might not be compliant 
to the medication prescribed to them or they might 
have difficulties when it comes to managing their own 
medicines. 
In the local scenario, these issues could be addressed 
during a medication review undertaken by the community 
pharmacist prior to dispensing the chronic medications 
through the POYC scheme.  When a medication review 
is conducted, maximum benefit of particular medication 
is sought and negative effects caused by one or more 
medication’s side effects or interactions eliminated.1   
Application of therapeutic guidelines to decide what 
action is needed and the implementation and monitoring 
of this action is of utmost importance.2,3 
The aims of this study consisted of performing a detailed 
examination of the patient’s medication regimen through 
a medication review exercise. Also, identification of any 
significant problem present in the medication regimen 
and amendment of these problems through discussions 
with the patient’s GP or specialist and the patient were 
undertaken. 
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Method 
Patients visiting the pharmacy to collect their medication 
through the POYC scheme had their medication regimen 
observed and recorded. This was done by looking through 
the patient’s medication record held at the community 
pharmacy where the study was carried out. Approval was 
granted from the managers of the community pharmacy 
and from the University of Malta Research and Ethics 
committee.
The patients which were selected had to be either; taking 
4 or more different types of medication, older than 60 
years of age, with special psychiatric needs, taking high 
risk medication (eg; drugs with a narrow therapeutic index) 
or patients experiencing particular undesirable effects 
through routine monitoring.  
A patient profile was set up which included the name, 
gender and history of medical conditions that the patient 
was suffering from. This profile also included a list of all the 
medications that the patient was taking, prescription and 
non- prescription medicines. 
When patients visited the pharmacy to collect their 
medicines each patient participating in the study was 
asked to answer a questionnaire. The questionnaire 
assessed through patients’ self- reporting, adherence to 
the prescribed medication regimen. Questions consisted 
of whether patients usually visited the same doctor or 
not and information about and frequency of medical 
check- ups. Patients were asked whether they received a 
full medical check- up when they collected their repeat 
prescription for their ‘free medicines’ or whether they 
just collected their repeat prescription with no further 
discussion. Also, patients were asked questions about 
taking medication regularly at the prescribed time, missing 
doses and reasons for poor compliance. Patients were 
asked to report any experienced side effects.
Following collection of this data, a check- list was set up by 
the pharmacist conducting the review. By using this tool, 
the pharmacist evaluated appropriateness of drug therapy 
and dosage regimen given to the patient, if there were 
any untreated or unnecessary indications, if duration of 
therapy was appropriate, if there were any interactions or 
side effects which could be avoided, if the regimen could 
be simplified and if the regimen was cost effective. All the 
information attained was recorded in the check- list. 
Results
Eighty patients participated in the study. Forty (50%) were 
male and 40 (50%) were female. All patients were Maltese. 
The average age for this population of patients was 69 
years (range: 37-91 years).
The most common types of conditions which these 
patients were suffering from were hypertension, 
hyperglycaemia and hypercholesterolaemia with 51 
(64%), 22 (28%) and 30 (38%) patients suffering from them 
respectively.  The average number of medications per 
patient was 6 different types of medication (range: 1- 34 
types of medication). Seventy patients (88%) claimed to 
usually visit the same doctor. The average frequency of 
medical check- ups was every 6 months (range: every week 
– every 3 years).
Thirty-seven patients (46%) claimed to receive a medical 
check-up and discuss their medication when they collect 
their repeat prescription from their doctor whilst the 
remaining 43 patients (54%) claimed to collect the repeat 
prescription with no thorough discussion. 
When assessing patient compliance to their medication, 
55 patients (69%), claimed to never miss a dose of their 
medication. The remaining 25 patients (31%) claimed to 
miss their dose of medication either rarely or more often. 
The majority of patients (77 patients; 96%) said that they 
usually took their medication at their prescribed time. 
Thirty-one patients (39%) reported that they experienced 
side effects which they knew were caused by their 
medication. 
From the check-list completed by the pharmacist, it 
was observed that 69 patients (86%) were receiving 
appropriate treatment for their condition. No patients 
had any untreated indications and no patients were being 
treated for unnecessary indications. Seventy- five patients 
(94%) had a constant need for the drugs being provided 
to them whilst the remaining 5 patients (6%) were taking 
medication which should have been stopped previously. 
Seventy out of the eighty patients (88%) were being 
administered an appropriate dosage regimen. A One Way 
ANOVA test indicated that patients being administered a 
relatively lower number of medications were those most 
likely to be receiving the most appropriate treatment 
(p= 0; Figure 1). Nineteen patients (24%) were at risk of 
significant drug interactions which could be minimized. 
For 72 patients (90%) there was duplication of treatment.
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Discussion
Results of this study show that most patients were 
receiving a considerable amount of poly- pharmacy. This 
could indicate the presence of various co- morbidities 
but could also indicate the fact that duplication of 
treatment prevails in this population. This could be due 
to the fact that although most patients usually visited 
the same doctor, a considerable amount of them visited 
different specialists and co- ordination of treatment was 
lacking. This reflects the need for medication review 
by the community pharmacist from where the patient 
is collecting the medicines through the POYC. In this 
scenario the pharmacist has a complete view of all 
medications being taken by the patient irrespective of 
disease, condition or specialist visited. 
Also such a process will reduce the risk that patients 
experience side effects caused by their medication. The 
community pharmacist can indeed help their patients 
use their medication more effectively and can support 
prescribers to select the most appropriate clinical or 
most cost effective treatment for the individual patient. 
Pharmacist-based medication review reduces the potential 
for drug- related problems.4 Continuity of care is of utmost 
importance when it comes to the delivery of health care of 
high quality.5 The community pharmacist is in a position 
to follow up on patients’ drug therapy in the primary care 
setting particularly in a scenario where patients may not 
be receiving a detailed medical check- up when getting 
the repeat prescriptions. 
Conclusion
In chronic disease management the presence of multiple 
prescribers and the lack of frequent reviews could present 
potential problems to the individual patient. Health- care 
professionals should collaborate to provide optimal 
therapy to all patients. Good education should be given 
to all patients regarding their treatment. Pharmacist-led 
medication reviews for patients on the POYC scheme 
should be proposed as this will lead to better patient 
monitoring, care and use of medicines. 
“Results of this study show 
that most patients were 
receiving a considerable 
amount of poly-pharmacy”
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Figure 1: Comparison of the number of medications with whether or not patients are receiving the most appropriate 
dosage regimen (n=80)
“In chronic disease 
management the 
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